Literature DB >> 32056322

Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study.

Upasana Tayal1,2, Ricardo Wage2, Simon Newsome3, Ramasamy Manivarmane4, Cemil Izgi2, Amal Muthumala5, Jason N Dungu6, Ravi Assomull7, Suzan Hatipoglu1,2, Brian P Halliday1,2, Amrit S Lota1,2, James S Ware1,2,8, John Gregson3, Michael Frenneaux1,9, Stuart A Cook10, Dudley J Pennell1,2, Andrew D Scott1,2, John G F Cleland1,2, Sanjay K Prasad1,2.   

Abstract

AIMS: There is an important need for better biomarkers to predict left ventricular (LV) remodelling in dilated cardiomyopathy (DCM). We undertook a comprehensive assessment of cardiac structure and myocardial composition to determine predictors of remodelling. METHODS AND
RESULTS: Prospective study of patients with recent-onset DCM with cardiovascular magnetic resonance (CMR) assessment of ventricular structure and function, extracellular volume (T1 mapping), myocardial strain, myocardial scar (late gadolinium enhancement) and contractile reserve (dobutamine stress). Regression analyses were used to evaluate predictors of change in LV ejection fraction (LVEF) over 12 months. We evaluated 56 participants (34 DCM patients, median LVEF 43%; 22 controls). Absolute LV contractile reserve predicted change in LVEF (1% increase associated with 0.4% increase in LVEF at 12 months, P = 0.02). Baseline myocardial strain (P = 0.39 global longitudinal strain), interstitial myocardial fibrosis (P = 0.41), replacement myocardial fibrosis (P = 0.25), and right ventricular contractile reserve (P = 0.17) were not associated with LV reverse remodelling. There was a poor correlation between contractile reserve and either LV extracellular volume fraction (r = -0.22, P = 0.23) or baseline LVEF (r = 0.07, P = 0.62). Men were more likely to experience adverse LV remodelling (P = 0.01) but age (P = 0.88) and disease-modifying heart failure medication (beta-blocker, P = 0.28; angiotensin-converting enzyme inhibitor, P = 0.92) did not predict follow-up LVEF.
CONCLUSIONS: Substantial recovery of LV function occurs within 12 months in most patients with recent-onset DCM. Women had the greatest improvement in LVEF. A low LV contractile reserve measured by dobutamine stress CMR appears to identify patients whose LVEF is less likely to recover.
© 2020 European Society of Cardiology.

Entities:  

Keywords:  Dilated cardiomyopathy; Dobutamine stress; Myocardial remodelling; Recovery

Mesh:

Substances:

Year:  2020        PMID: 32056322     DOI: 10.1002/ejhf.1734

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  8 in total

1.  Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy.

Authors:  Brian P Halliday; Ruth Owen; John Gregson; Ali Vazir; Rebecca Wassall; Zohya Khalique; Amrit S Lota; Upasana Tayal; Daniel J Hammersley; Richard E Jones; Dudley J Pennell; Martin R Cowie; John G F Cleland; Sanjay K Prasad
Journal:  ESC Heart Fail       Date:  2022-03-08

2.  Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data.

Authors:  Upasana Tayal; Job A J Verdonschot; Mark R Hazebroek; James Howard; John Gregson; Simon Newsome; Ankur Gulati; Chee Jian Pua; Brian P Halliday; Amrit S Lota; Rachel J Buchan; Nicola Whiffin; Lina Kanapeckaite; Resham Baruah; Julian W E Jarman; Declan P O'Regan; Paul J R Barton; James S Ware; Dudley J Pennell; Bouke P Adriaans; Sebastiaan C A M Bekkers; Jackie Donovan; Michael Frenneaux; Leslie T Cooper; James L Januzzi; John G F Cleland; Stuart A Cook; Rahul C Deo; Stephane R B Heymans; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2022-06-07       Impact factor: 27.203

3.  Myocardial recovery evaluation from ventricular assist device in patients with dilated cardiomyopathy.

Authors:  Takayuki Gyoten; Eisuke Amiya; Osamu Kinoshita; Masaki Tsuji; Mitsutoshi Kimura; Masaru Hatano; Minoru Ono
Journal:  ESC Heart Fail       Date:  2022-05-10

4.  A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.

Authors:  Yuki Kimura; Takahiro Okumura; Ryota Morimoto; Shingo Kazama; Naoki Shibata; Hideo Oishi; Takashi Araki; Takashi Mizutani; Tasuku Kuwayama; Hiroaki Hiraiwa; Toru Kondo; Toyoaki Murohara
Journal:  ESC Heart Fail       Date:  2021-01-20

Review 5.  Quantification of Myocardial Deformation Applying CMR-Feature-Tracking-All About the Left Ventricle?

Authors:  Torben Lange; Andreas Schuster
Journal:  Curr Heart Fail Rep       Date:  2021-05-01

6.  Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy.

Authors:  Daniela Fecht; Marc Chadeau-Hyam; Ruth Owen; John Gregson; Brian P Halliday; Amrit S Lota; John Gulliver; James S Ware; Dudley J Pennell; Frank J Kelly; Anoop S V Shah; Mark R Miller; David E Newby; Sanjay K Prasad; Upasana Tayal
Journal:  J Card Fail       Date:  2022-01-11       Impact factor: 6.592

7.  Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses.

Authors:  Xiqiang Wang; Xiude Fan; Qihui Wu; Jing Liu; Linyan Wei; Dandan Yang; Xiang Bu; Xiaoxiang Liu; Aiqun Ma; Tomohiro Hayashi; Gongchang Guan; Yu Xiang; Shuang Shi; Junkui Wang; Jiansong Fang
Journal:  Front Cardiovasc Med       Date:  2022-07-15

8.  Effects of Levosimendan on cardiac function, size and strain in heart failure patients.

Authors:  D Beitzke; F Gremmel; D Senn; R Laggner; A Kammerlander; A Wielandner; R Nolz; M Hülsmann; C Loewe
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-24       Impact factor: 2.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.